This is the authors' abstract. We don't add key points for this paper.
Imidazolin-2-imino-functionalized tetramethylcyclopentadienes 3 -H have been prepared in high yields by the reaction of 2 equiv of 1,3,4,5-tetramethylimidazolin-2-imine ( 1a ), 1,3-diisopropyl-4,5-dimethylimidazolin-2-imine ( 1b ), and 1,3-di -tert- butylimidazolin-2-imine ( 1c ) with 5-(chlorodimethylsilyl)-1,2,3,4-tetramethyl-1,3-cyclopentadiene ( 2 ), whereas the corresponding indene 6- H has been obtained from the reaction of 1b with 1-(chlordimethylsilyl)indene ( 5 ). Deprotonation of 3 -H and 6 -H with the Schlosser base (KO t Bu/ n BuLi) affords the highly reactive potassium salts ( 3 )K and ( 6 )K, which are useful precursors for the coordination of these ligands to transition metals. The chromium complexes 4a, 4b, 4c, and 7 have been prepared by salt metathesis reactions of ( 3 )K and ( 6 )K with [CrCl 3 (THF) 3 ], and the molecular structures of all four paramagnetic complexes have been established by X-ray diffraction analyses. In the case of 4a, 4b, and 7, the formation of constrained-geometry complexes with chelating Me 2 Si-bridged cyclopentadienyl-imidazolin-2-imine ligands is observed. The presence of short Cr−N bonds is indicative of the strong electron-donating capacity of the imidazoline-2-imino-nitrogen atom, which is based on the ability of the imidazolium ring to effectively stabilize a positive charge. In contrast, the steric bulk of the tert- butyl groups in 4c prevents coordination of the imine moiety. Activation of the chromium complexes 4 and 7 with methylaluminoxane (MAO) affords catalysts for the polymerization of ethylene at ambient temperature and under normal pressure.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Randoll et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: